These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3495671)

  • 1. Reduction of bladder cancer growth in mice treated with intravesical Bacillus Calmette Guerin and systemic interleukin 2.
    Lee KE; Weiss GH; O'Donnell RW; Cockett AT
    J Urol; 1987 Jun; 137(6):1270-3. PubMed ID: 3495671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the immunologic mechanism of intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors: distribution and function of immune cells.
    Chung JY; Lee ES; Lee WJ; Kim HH; Min KJ; Lee C
    J Korean Med Sci; 1993 Apr; 8(2):135-44. PubMed ID: 8397930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy of interleukin 2 with cyclophosphamide or bacillus Calmette-Guérin against implanted bladder cancer cells in mice.
    Wada S; Ikemoto S; Terada T; Tanaka H; Kamizuru M; Sakamoto W; Kishimoto T; Maekawa M
    Urol Int; 1991; 47 Suppl 1():104-7. PubMed ID: 1949363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
    Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
    Cancer Res; 1983 Apr; 43(4):1611-5. PubMed ID: 6339040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of interleukin 2 and bacillus Calmette-Guérin in the therapy of mice with transitional cell carcinoma.
    Ikemoto S; Kamizuru M; Wada S; Nishio S; Kishimoto T; Maekawa M
    Urol Int; 1991; 47(4):250-4. PubMed ID: 1781111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon.
    Böhle A; Thanhäuser A; Ulmer AJ; Ernst M; Flad HD; Jocham D
    J Urol; 1993 Dec; 150(6):1932-7. PubMed ID: 8230540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.
    Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
    J Urol; 1984 Jan; 131(1):139-42. PubMed ID: 6418894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
    Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
    Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer.
    Chin JL; Kadhim SA; Batislam E; Karlik SJ; Garcia BM; Nickel JC; Morales A
    J Urol; 1996 Sep; 156(3):1189-93. PubMed ID: 8709344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential immunocytological evaluation of murine transitional cell carcinoma during intralesional bacillus Calmette-Guerin and interleukin-2 immunotherapy.
    Sosnowski JT; De Haven JI; Abraham FM; Riggs DR; Lamm DL
    J Urol; 1992 May; 147(5):1439-43. PubMed ID: 1569700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor effect of Bacillus Calmette-Guérin in combination with fibrinogen on urinary bladder tumor.
    Mizutani Y; Nio Y; Fukumoto M; Yoshida O
    J Urol; 1994 May; 151(5):1420-6. PubMed ID: 8158799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cells are essential for effective BCG immunotherapy.
    Brandau S; Riemensberger J; Jacobsen M; Kemp D; Zhao W; Zhao X; Jocham D; Ratliff TL; Böhle A
    Int J Cancer; 2001 Jun; 92(5):697-702. PubMed ID: 11340575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
    Lamm DL; DeHaven JI; Shriver J; Sarosdy MF
    J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin.
    De Boer EC; De Jong WH; Steerenberg PA; Van der Meijden AP; Aarden LA; Debruyne FM; Ruitenberg EJ
    In Vivo; 1991; 5(6):671-7. PubMed ID: 1810454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumour necrosis factor-alpha (TNF-alpha) mRNA in bladders and spleens of mice after intravesical administration of bacillus Calmette-Guérin.
    Shin JS; Park JH; Kim JD; Lee JM; Kim SJ
    Clin Exp Immunol; 1995 Apr; 100(1):26-31. PubMed ID: 7697918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: lack of a role of natural killer cells.
    Ratliff TL; Shapiro A; Catalona WJ
    Clin Immunol Immunopathol; 1986 Oct; 41(1):108-15. PubMed ID: 3527506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment.
    Hori S; Miyake M; Tatsumi Y; Morizawa Y; Nakai Y; Onishi S; Onishi K; Iida K; Gotoh D; Itami Y; Tanaka N; Fujimoto K
    Oncol Rep; 2019 Mar; 41(3):1863-1874. PubMed ID: 30628699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination immunotherapy of murine transitional cell cancer using BCG and an interferon-inducing pyrimidinone.
    Sarosdy MF; Kierum CA
    J Urol; 1989 Nov; 142(5):1376-9. PubMed ID: 2810534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of murine bladder cancer by irradiated tumor vaccine.
    Lamm DL; Riggs DR; DeHaven JI; Bryner RW
    J Urol; 1991 Jan; 145(1):195-8. PubMed ID: 1984090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
    Yutkin V; Pode D; Pikarsky E; Mandelboim O
    J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.